Fig. 4.
Effects of evogliptin, leucine, and the combination of these two agents on hepatic steatosis in HFD-fed mice. After eight weeks of the administration of evogliptin, leucine, or their combination in HFD-fed mice, the degree of hepatic steatosis was assessed by examining hepatic lipid accumulation histologically (A) and biochemically (B). Data are expressed as the means ± SEM. #p<0.05 vs. normal control mice, *p<0.05 vs. HFD-fed control mice.
